
Publication|Articles|October 10, 2025
- October 2025
- Volume 91
- Issue 10
FDA Approvals for September 2025
Author(s)PT Staff
Key Takeaways
- Recent FDA approvals highlight advancements in oncology, focusing on therapies targeting specific genetic mutations for personalized treatment.
- Expedited review processes by the FDA have enabled quicker access to innovative cancer treatments, improving patient outcomes.
Explore recent FDA-approved drugs from September 2025.
Advertisement
FDA Approvals
Articles in this issue
about 1 month ago
Recognizing Immunizing Pharmacists in the Communityabout 1 month ago
Burnout Among Pharmacy Technicians Demands Urgent Actionabout 1 month ago
Court Ruling Highlights Risks of Improper Dose Adjustmentsabout 1 month ago
Clinical Pharmacology Update: Leqembi Iqlik From Eisaiabout 1 month ago
Patient Education Is Key to Improving Medication Adherenceabout 1 month ago
Addressing Substance Abuse Requires Heightened Awarenessabout 1 month ago
OTC Case Studies: Dry EyeNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Updated Hypertension Guidelines Are Here
2
FDA Approves Reformulated Ranitidine After 5-Year Absence
3
Carefully Consider Ethical Implications of Artificial Intelligence Use in Pharmacy
4
Application of the Age-Friendly 4M’s Movement Across Different Areas of Pharmacy
5


















































































































































































































